Office of the Secretary October 30, 2020 – Federal Register Recent Federal Regulation Documents

Notice of Rights and Protections Available Under the Federal Antidiscrimination and Whistleblower Protection Laws
Document Number: 2020-24133
Type: Notice
Date: 2020-10-30
Agency: Department of Transportation, Office of the Secretary
This Notice implements Title II of the Notification and Federal Employee Antidiscrimination and Retaliation Act of 2002 (No FEAR Act of 2002). In doing so, the Department of Transportation notifies all employees, former employees, and applicants for Federal employment of the rights and protections available to them under the Federal Anti-discrimination and Whistleblower Protection Laws.
Proposed Collection; Comment Request
Document Number: 2020-24121
Type: Notice
Date: 2020-10-30
Agency: Department of Defense, Office of the Secretary
In compliance with the Paperwork Reduction Act of 1995, the Office of the Under Secretary of Defense for Acquisition and Sustainment announces a proposed public information collection and seeks public comment on the provisions thereof. Comments are invited on: Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; the accuracy of the agency's estimate of the burden of the proposed information collection; ways to enhance the quality, utility, and clarity of the information to be collected; and ways to minimize the burden of the information collection on respondents, including through the use of automated collection techniques or other forms of information technology.
TRICARE Coverage of National Institute of Allergy and Infectious Disease Coronavirus Disease 2019 Clinical Trials
Document Number: 2020-24114
Type: Rule
Date: 2020-10-30
Agency: Department of Defense, Office of the Secretary
The Assistant Secretary of Defense for Health Affairs (ASD(HA)) issues this interim final rule (IFR) with request for comments to temporarily modify the TRICARE regulation by adding coverage for National Institute of Allergy and Infectious Disease (NIAID)-sponsored clinical trials for the treatment or prevention of coronavirus disease 2019 (COVID-19).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.